絞り込み

16402

広告

894件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Simultaneous quantification of direct oral anticoagulants currently used in anticoagulation therapy.

Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with direct oral anticoagulant.

Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention.

Novel Anticoagulant Therapy of Venous Thromboembolism: Current Status and Future Directions.

Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.

Assessing Bleeding Risk in Patients With Intentional Overdoses of Novel Antiplatelet and Anticoagulant Medications.

Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants.

Direct Oral Anticoagulants in Cardioversion: A Review of Current Evidence.

Use of Guidelines for Reducing Stroke Risk in Patients With Nonvalvular Atrial Fibrillation: A Review From a Latin American Perspective.

Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.

Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.

Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM).

Reversing factor Xa inhibitors - clinical utility of andexanet alfa.

Pharmacological and Non-pharmacological Treatments for Stroke Prevention in Patients with Atrial Fibrillation.

Discovery methods of coagulation-inhibiting drugs.

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis.

Edoxaban improves venous thrombosis via increasing hydrogen sulfide and homocysteine in rat model.

Cholesterol Crystal Embolism Induced by Direct Factor Xa inhibitor: A First Case Report.

Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.

Edoxaban is effective in reducing the incidence of asymptomatic phlebographic events following closed-wedge high tibial osteotomy.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります